Caplight Logo









Miaoshou Doctor

Miaoshou Doctor

Private
Beijing, BeijingHealthcare & Life Scienceswww.miaoshou.net

Last Round

Series F

Aug 3, 2021

Est. Valuation

$4.25B

Total Funding Raised

$938.76M

Company Overview

Miaoshou Doctor is a healthcare technology company that offers a patient management and communication platform enabling healthcare professionals and patients to effectively manage post-diagnosis outcomes through follow-up counseling and prescriptions.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, E-commerce, Telemedicine, Patient Engagement, InsurTech

Business Model

B2B2C

Customer Profile

Hardware Sales, Services & Consulting, Subscription SaaS

AI Layer

Non-AI

Keywords

prescription drug platformonline pharmacyretail pharmacy networkO2O healthcareonline medical consultationtelemedicinedigital healthhealthtechout-of-hospital carepatient managementdisease managementhospital-side pharmacydrug wholesaleInsurTechpharmacy benefits managementEMR systems

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Miaoshou Doctor Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Miaoshou Doctor Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series FAug 3, 2021
Series EFeb 9, 2021
Series DJun 15, 2020
Series C ExtensionJun 27, 2019
Series C ExtensionJan 7, 2019
Series C
Apr 2, 2018

Miaoshou Doctor Investors

Notable investors and investment history

InvestorRounds
Starworld CapitalSeries C Extension
Gopher Asset ManagementSeries E
Hel Ved Capital ManagementSeries F
CITIC SecuritiesSeries F, Series E, Series D
B Capital GroupSeries F
E Fund Management (HK)Series F
Index CapitalSeries F, Series E, Series D

Miaoshou Doctor Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Miaoshou Doctor Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Miaoshou Doctor's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing, Beijing
Year Founded2015
Last FundingAug 3, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.